Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design.
Saved in:
| Title: | Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design. |
|---|---|
| Authors: | Momčilović M; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia., Šitum I; Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy, University Hospital Centre Zagreb, Zagreb, Croatia., Erceg A; Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy, University Hospital Centre Zagreb, Zagreb, Croatia., Siroglavić M; Department of Clinical Microbiology, Infection Prevention and Control, University Hospital Centre Zagreb, Zagreb, Croatia., Lovrić M; Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Nižić Nodilo L; Department of Pharmaceutical Technology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia., Hafner A; Department of Pharmaceutical Technology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia., Lovrić J; Department of Pharmaceutical Technology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia., Turčić P; Department of Pharmacology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia., Fabijanović D; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia., Marinić A; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia., Nedeljković V; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia., Pašalić M; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia., Perčin L; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia., Šipuš D; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia., Miličić D; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia., Lovrić D; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Aug 07; Vol. 16, pp. 1618987. Date of Electronic Publication: 2025 Aug 07 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40852616 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Momčilović+M%22">Momčilović M</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Šitum+I%22">Šitum I</searchLink>; Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Erceg+A%22">Erceg A</searchLink>; Department of Anesthesiology, Reanimatology, Intensive Medicine and Pain Therapy, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Siroglavić+M%22">Siroglavić M</searchLink>; Department of Clinical Microbiology, Infection Prevention and Control, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Lovrić+M%22">Lovrić M</searchLink>; Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.; University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Nižić+Nodilo+L%22">Nižić Nodilo L</searchLink>; Department of Pharmaceutical Technology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Hafner+A%22">Hafner A</searchLink>; Department of Pharmaceutical Technology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Lovrić+J%22">Lovrić J</searchLink>; Department of Pharmaceutical Technology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Turčić+P%22">Turčić P</searchLink>; Department of Pharmacology, University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Fabijanović+D%22">Fabijanović D</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Marinić+A%22">Marinić A</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Nedeljković+V%22">Nedeljković V</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Pašalić+M%22">Pašalić M</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Perčin+L%22">Perčin L</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Šipuš+D%22">Šipuš D</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Miličić+D%22">Miličić D</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.; School of Medicine, University of Zagreb, Zagreb, Croatia.<br /><searchLink fieldCode="AU" term="%22Lovrić+D%22">Lovrić D</searchLink>; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, Zagreb, Croatia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2025 Aug 07; Vol. 16, pp. 1618987. <i>Date of Electronic Publication: </i>2025 Aug 07 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40852616 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2025.1618987 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1618987 Titles: – TitleFull: Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Momčilović M – PersonEntity: Name: NameFull: Šitum I – PersonEntity: Name: NameFull: Erceg A – PersonEntity: Name: NameFull: Siroglavić M – PersonEntity: Name: NameFull: Lovrić M – PersonEntity: Name: NameFull: Nižić Nodilo L – PersonEntity: Name: NameFull: Hafner A – PersonEntity: Name: NameFull: Lovrić J – PersonEntity: Name: NameFull: Turčić P – PersonEntity: Name: NameFull: Fabijanović D – PersonEntity: Name: NameFull: Marinić A – PersonEntity: Name: NameFull: Nedeljković V – PersonEntity: Name: NameFull: Pašalić M – PersonEntity: Name: NameFull: Perčin L – PersonEntity: Name: NameFull: Šipuš D – PersonEntity: Name: NameFull: Miličić D – PersonEntity: Name: NameFull: Lovrić D IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 08 Text: 2025 Aug 07 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |
